Mehrdad Payandeh

Mehrdad Payandeh

Auto-generated profile, based on publicly available information

Mehrdad Payandeh

Clinical Research Development Center, Taleghani and Imam Ali Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 January 2019 in BMC Cancer
Verified
Journal Article
Open access
PDF file
NKNiloofar Khodabandehlou
Niloofar Khodabandehlou
SMShayan Mostafaei
Shayan Mostafaei
AEAshkan Etemadi
Ashkan Etemadi
AGAmir Ghasemi
Amir Ghasemi
MPMehrdad Payandeh
Mehrdad Payandeh
MMMohsen Moghoofei
Mohsen Moghoofei
Breast cancer is currently the most common neoplasm diagnosed in women globally. There is a growing body of evidence to suggest that human papillomavirus (HPV) infection may play a key role in invasiveness of breast cancer. The aim of this study was to determine the presence of HPV in patients with breast cancer and its possible association with cancer progression. Breast specimens were collected from 72 patients with breast cancer and 31 healthy controls. The presence of HPV was investigated by polymerase chain reaction (PCR) and genotyping was performed for positive cases. We also evaluated the viral factors such as E6, E2, and E7 in HPV positive cases. Enzyme-linked immunosorbent assay (ELISA (and Real-time PCR techniques were used to measure the expression level of anti-carcinogenic genes, such as p53, retinoblastoma (RB), breast and ovarian cancer susceptibility gene (BRCA1, BRCA2) and inflammatory cytokines, including tumor necrosis factor α (TNF-α), transforming growth factor β (TGF-β), nuclear factor-kB (NF-kB), and different interleukins [ILs] (IL-1,IL6, and IL-17). The HPV DNA was detected in 48.6% of breast cancer samples, whereas only 16.1% of controls were positive for HPV. We observed statistically significant differences between breast cancer patients and HPV presence (P = 0.003). HPV type 18 was the most prevalent virus genotype in patients. The expression of P53, RB, BRCA1, and BRCA2 were decreased in patients with HPV-positive breast cancer as compared to HPV-negative breast cancer and healthy controls. (All P-values were less than 0.05). The presence of the HPV was associated with increased inflammatory cytokines (IL-1, IL-6, IL-17, TGF-β, TNF-α, and NF-kB) and tumor progression. The present study demonstrated that HPV infection may implicate in the development of some types of breast cancer.

3 December 2015 in Asian Pacific Journal of Cancer Prevention
Verified
Journal Article
Open access
PDF file
ASAli Shahriari-Ahmadi
Ali Shahriari-Ahmadi
AFAli Fahimi
Ali Fahimi
MPMehrdad Payandeh
Mehrdad Payandeh
Masoud SadeghiMasoud Sadeghi
Masoud Sadeghi
The chemotherapeutic agent oxaliplatin can cause acute and chronic forms of peripheral neuropathy. The aim of this study was to evaluate the incidence of chronic neuropathy and its risk factors in colorectal cancer (CRC) patients treated with FOLFOX or XELOX regimens in the Oncology Ward of Hazrat-e-Rasoul Hospital in Tehran. A total of 130 patients with CRC were entered into our study, aged over 18 years, without history of receiving other neurotoxic agents or other predisposing factors such as diabetes or neurologic diseases and kidney and liver dysfunction. For the FOLFOX regimen, patients received oxaliplatin, 85 mg/m2, every 2 weeks for 12 courses and with the XELOX regimen, oxaliplatin was 130 mg/m(2), every 3 weeks for 8 courses. Based on Common Toxicity Criteria (CTC or NCI-CTC v.3), the patients were divided into 5 groups (grades) based on the severity of their symptoms. Fifty-seven patients (43.8%) were male and 73(56.2%) female. Some 19 patients (14.7%) had BMI<20, 97(74.6%) were between 20-25 and 14 (10.8%) ≥ 25. In 105 patients (80.7%) neuropathy was found. There was significant correlation between BMI, hypomagnesaemia and especially, severity of anemia in patients with neuropathy compared to those without. Oxaliplatin regimens can induce chronic neuropathy in CRC patients, with anemia, high BMI and hypomagnesaemia as risk factors that can predispose to this kind of neurotoxicity.

19 August 2011 in Haemophilia
Verified
Journal Article
Closed access
PDF file
MKMehran Karimi
Mehran Karimi
AVA. Vafafar
A. Vafafar
SHSezaneh Haghpanah
Sezaneh Haghpanah
MPM. Payandeh
M. Payandeh
PEP. Eshghi
P. Eshghi
FPFlora Peyvandi
Flora Peyvandi

1 April 2016 in Indian Journal of Medical and Paediatric Oncology
Verified
Journal Article
Open access
PDF file
SMSeyed-Hamid Madani
Seyed-Hamid Madani
MPMehrdad Payandeh
Mehrdad Payandeh
Masoud SadeghiMasoud Sadeghi
Masoud Sadeghi
HMHajar Motamed
Hajar Motamed
ESEdris Sadeghi
Edris Sadeghi
Context: Despite the fact that breast cancer (BC) is a major health issue, very few studies describe its characteristics in the Middle East. Aim: The aim of this study was to evaluate the use and value of Ki-67 as a prognostic marker in BC and associations between Ki-67, clinical, and histopathological parameters were evaluated. Subjects and Methods: In a retrospective study, 260 BC women and invasive ductal carcinoma were included to our study in Kermanshah city, Iran. Age, tumor size, lymph node involvement, histological grade, nuclear grade, and vascular invasion were other factors that determined in a lot of patients. Results: The mean age at diagnosis was 47.6 years (range, 24-84 years) with 100% female. Of 243 patients that tumor size was determined for them, 207 patients (85.2%) had tumor size ≥ 2 cm, and 36 patients (14.8%) had size <2 cm and also of 237 patients, 47 patients (19.8%), 140 (59.1%), and 50 (21.1%) had histological grades I, II, and III, respectively. There is significant correlation between Ki-67 with nuclear grade, human epidermal growth factor receptor 2 (HER2), and p53 (P < 0.05). Based on this result, more patients with Ki-67 ≥ 20% have higher nuclear grade, p53-positive, and HER2-positive. There was correlation between Ki-67 with type of tumor (P = 0.009). Conclusions: The higher Ki-67 has a direct significant correlation with higher nuclear grade, p53-positive, and HER2-positive. Furthermore, triple negative patients have higher Ki-67 compared to other subtypes.

6 December 2021 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
ANAmir Hossein Norooznezhad
Amir Hossein Norooznezhad
RYReza Yarani
Reza Yarani
MPMehrdad Payandeh
Mehrdad Payandeh
ZHZohreh Hoseinkhani
Zohreh Hoseinkhani
SKSarah Kiani
Sarah Kiani
KMKamran Mansouri
Kamran Mansouri
Click on the article title to read more.